Stock NLSP NLS PHARMACEUTICS AG
Add to a list
To use this feature you must be a member
Log inSign up

Company NLS Pharmaceutics AG

Equities

NLSP

CH0523961370

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 21:30:00 25/06/2024 BST 		5-day change 1st Jan Change
0.1684 USD -5.61% Intraday chart for NLS Pharmaceutics AG -37.65% -71.45%
06-11 NLS Pharmaceutics AG Publication of New Patent Application for Next-Gen Dual Non-Sulfonamide Orexin Receptor Agonists CI
06-11 NLS Pharmaceutics Says New Patent Application for Dual Non-Sulfonamide Orexin Receptor Agonists Published by WIPO MT

Business Summary

NLS Pharmaceutics AG, formerly NLS 1 Pharma AG, is a Switzerland-based company that operates as a biopharmaceutical company. The Company focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The Company serves customers worldwide.

Managers

Managers TitleAgeSince
Eric Konofal FOU
 Founder 56 09/06/15
Alexander Zwyer FOU
 Founder 55 09/06/15
Elena Thyen-Pighin DFI
 Director of Finance/CFO 52 19/05/23
George Apostol CTO
 Chief Tech/Sci/R&D Officer 51 07/09/22
Hervé Girsault PRN
 Corporate Officer/Principal 64 31/08/16

Members of the board

Members of the board TitleAgeSince
Audrey Greenberg BRD
 Director/Board Member 51 29/06/23
Alexander Zwyer FOU
 Founder 55 09/06/15
Ronald Hafner FOU
 Founder 60 09/06/15
Gian-Marco Rinaldi Diaz de la Cruz BRD
 Director/Board Member 51 16/06/21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 42,806,136 27,083,431 ( 63.27 %) 3,242,887 ( 7.576 %) 63.27 %

Shareholders

NameEquities%Valuation
BVF, Inc.
13.25 %
5,747,126 13.25 % 810 345 $
The Lind Partners LLC
9.911 %
4,300,000 9.911 % 606 300 $
Yorkville Advisors Global LP
9.126 %
3,959,128 9.126 % 558 237 $
Felix Grisard
7.475 %
3,242,889 7.475 % 457 247 $
Magnetic Rock Investment AG
6.558 %
2,845,000 6.558 % 401 145 $
Armistice Capital LLC
5.006 %
2,172,000 5.006 % 306 252 $
Ronald Hafner
4.775 %
2,071,710 4.775 % 292 111 $
Alexander Zwyer
3.684 %
1,598,133 3.684 % 225 337 $
George Apostol
3.144 %
1,363,916 3.144 % 192 312 $
Eric Konofal
2.544 %
1,103,659 2.544 % 155 616 $
NameEquities%Valuation
Armistice Capital LLC
-
500,000 - 13 500 $
Altium Capital Management LP
-
200,000 - 5 400 $
Hudson Bay Capital Management LP
-
100,000 - 2 700 $
G1 Execution Services LLC
-
12,548 - 339 $
Clear Street LLC
-
8,577 - 232 $
UBS Securities LLC
-
6,023 - 163 $

Company contact information

NLS Pharmaceutics Ltd.

The Circle 6

8058, Zurich

+

http://www.nlspharma.com
address NLS Pharmaceutics AG(NLSP)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
NLS PHARMACEUTICS AG Stock NLS Pharmaceutics AG
-71.45% 7.16M
MODERNA, INC. Stock Moderna, Inc.
+38.36% 52.5B
LONZA GROUP AG Stock Lonza Group AG
+36.73% 39.31B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-8.63% 39.01B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
+25.46% 28.2B
CELLTRION, INC. Stock Celltrion, Inc.
-11.17% 26.57B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.44% 26.2B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+45.09% 14.15B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+32.93% 12.62B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-5.30% 11.74B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. NLSP Stock
  4. Company NLS Pharmaceutics AG